X4 Pharmaceuticals, Inc. (XFOR) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for X4 Pharmaceuticals, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:05.050 Greetings and welcome to the X4 Pharmaceuticals fourth quarter and full year 2023 00:00:05.050 -- 00:00:08.511 financial and operating results conference call. 00:00:08.511 -- 00:00:11.871 At this time, all participants are in a listen-only mode. 00:00:11.871 -- 00:00:15.792 A question and answer session will follow the formal presentation. 00:00:15.792 -- 00:00:19.213 As a reminder, this conference is being recorded. 00:00:19.213 -- 00:00:24.454 It is now my pleasure to introduce your host, Dan Ferry from LifeSci Advisors. 00:00:24.454 -- 00:00:26.714 Please begin. 00:00:26.975 -- 00:00:30.011 Thank you, Operator, and good morning, everyone. 00:00:30.011 -- 00:00:33.852 Presenting on today's call will be X4's Chief Executive Officer, Dr. 00:00:33.852 -- 00:00:38.352 Paula Regan, and Chief Financial Officer, Adam Mostafa. 00:00:38.352 -- 00:00:42.753 Following prepared remarks by each, we will open the call to your questions, and we'll 00:00:42.753 -- 00:00:48.614 be joined by Chief Commercial Officer, Mark Baldry, Chief Medical Officer, Dr. 00:00:48.614 -- 00:00:53.815 Christoph Arbit Engels, Chief Operating Officer, Mary DiPiase, 00:00:53.815 -- 00:00:58.055 and Chief Scientific Officer, Art Tavares. 00:00:58.216 -- 00:01:02.302 As a reminder on today's call, the company will be making forward-looking statements 00:01:02.302 -- 00:01:07.825 regarding regulatory and product development plans, as well as research activities. 00:01:07.825 -- 00:01:11.088 These statements are subject to risks and uncertainties that may cause actual results 00:01:11.088 -- 00:01:13.950 to differ from those forecasted. 00:01:13.950 -- 00:01:18.633 Description of these risks can be found in XFOR's most recent filings with the SEC, including 00:01:18.633...